THTX: חוב לטווח קצר של החברה Theratechnologies Inc.

Current price action for Theratechnologies Inc. (THTX) on the GURU.Markets platform demonstrates a value of 0.00, driven by a transition toward profitable sales growth of specialized HIV treatments and a reduction in oncology R&D expenditures. The business relies on outsourcing production cycles and testing to third-party contractors, while utilizing external marketing for the global promotion of its therapeutic solutions.

This metric measures the total volume of liabilities with a maturity of up to one year. By analyzing the short-term debt profile, an investor assesses liquidity and the absence of settlement distortions. The metric is sensitive to payment regularity, where a steady reduction of risks protects capital. For Theratechnologies Inc. (THTX), a low debt load confirms business resilience, enabling the company to effectively monetize stable demand for vital endocrine drugs.